#lsd — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #lsd, aggregated by home.social.
-
#LSD: "#AlbertHoffman resolveu experimentar uma droga sintetizada por ele em laboratório em abril de 1943; quando ele voltava para casa de bicicleta, começaram a surgir os efeitos alucinógenos."
Ouça áudio de reportagem de Greg McKevitt, da BBC Culture. Narração de Thomas Pappon.
-
Free download codes:
DRNO1 - Simulation Theory (prod. by Deep N Beeper)
"Simulation Theory N BASS!!!!!"
#bass #hiphoprap #dnb #grime #140 #consciousrap #amenbreak #amens #cybergrime #lsd #psychonaut #simulation #simulationtheory #music
-
Free download codes:
Sean Cocktail - Shaken Not Stirred
"Classical guitar genes in DnB's DNA! Who would've thunk it?"
#electronic #electronica #idm #experimentalelectronic #bass #classicalguitar #deepmusic #experimentaldnb #futurejungle #lsd #music
-
Free download codes:
Sean Cocktail - Shaken Not Stirred
"Classical guitar genes in DnB's DNA! Who would've thunk it?"
#electronic #electronica #idm #experimentalelectronic #bass #classicalguitar #deepmusic #experimentaldnb #futurejungle #lsd #music
-
Free download codes:
Sean Cocktail - Shaken Not Stirred
"Classical guitar genes in DnB's DNA! Who would've thunk it?"
#electronic #electronica #idm #experimentalelectronic #bass #classicalguitar #deepmusic #experimentaldnb #futurejungle #lsd #music
-
Free download codes:
Sean Cocktail - Shaken Not Stirred
"Classical guitar genes in DnB's DNA! Who would've thunk it?"
#electronic #electronica #idm #experimentalelectronic #bass #classicalguitar #deepmusic #experimentaldnb #futurejungle #lsd #music
-
How #Psychedelics Affect the #Brain
Researchers sought to demonstrate therapeutic benefits of mind-altering drugs like #LSD and #psilocybin “#magicmushrooms,” many struggled to explain how these compounds work.
New studies included more than 500 scans of 267 research participants on five substances: LSD, psilocybin, mescaline, DMT and ayahuasca. Research suggests psychedelics temporarily reduce separation between how we think and how we perceive.
https://www.nytimes.com/2026/04/07/health/psychedelic-medicine-brain.html
https://archive.ph/2sCpu -
Free download codes:
Ricochet - ADHD (Ft. Onepacman & Hels)
"ADHD n BASS!!!!! Dubstepish vibes"
#trap #beats #triphop #guitar #bass #dubstep #hiphoprap #undergroundhiphop #adderall #adhd #experimentalhiphop #lsd #pagan #psychology #southampton #music
-
Free download codes:
Ricochet - ADHD (Ft. Onepacman & Hels)
"ADHD n BASS!!!!! Dubstepish vibes"
#trap #beats #triphop #guitar #bass #dubstep #hiphoprap #undergroundhiphop #adderall #adhd #experimentalhiphop #lsd #pagan #psychology #southampton #music
-
Free download codes:
Ricochet - ADHD (Ft. Onepacman & Hels)
"ADHD n BASS!!!!! Dubstepish vibes"
#trap #beats #triphop #guitar #bass #dubstep #hiphoprap #undergroundhiphop #adderall #adhd #experimentalhiphop #lsd #pagan #psychology #southampton #music
-
Free download codes:
Ricochet - ADHD (Ft. Onepacman & Hels)
"ADHD n BASS!!!!! Dubstepish vibes"
#trap #beats #triphop #guitar #bass #dubstep #hiphoprap #undergroundhiphop #adderall #adhd #experimentalhiphop #lsd #pagan #psychology #southampton #music
-
DATE: May 11, 2026 at 10:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: New study explores the link between mystical psychedelic trips and a reduced fear of dying
A new study published in the Journal of Psychedelic Studies has found that people who have had a meaningful psychedelic experience report a significantly reduced fear of death, alongside heightened feelings of connection to themselves, others, and the world around them. Furthermore, the degree of connection closely tracks the degree of relief from death-related fear.
Researchers have long argued that anxiety about dying sits at the root of a surprisingly wide range of psychological struggles, from depression to broader existential distress. Studies have observed that psychedelic experiences—first noted in terminally ill patients in the mid-20th century and later confirmed in modern controlled research—can drastically reduce this fear, though the mechanisms behind why this happens remain unclear.
One leading explanation is increased connectedness: a heightened sense of relationship to oneself, others, and the wider world. Because psychedelics reliably enhance these feelings, researchers sought to investigate whether greater connectedness might be one of the specific pathways through which psychedelics reduce the fear of death.
Led by Noah N. Barr at the University of Wollongong in Australia, the team recruited 106 adults (59 male, 44 female, 2 non-binary; average age 31 years) who had undergone a personally meaningful psychedelic experience using a classical substance. Psilocybin (the active compound in “magic mushrooms”) was the most common, though LSD, ayahuasca, DMT, and mescaline were also represented.
Using an anonymous online survey, participants reflected retrospectively on the three months before and the three months after their experience. They completed validated questionnaires measuring their fear of death, their tendency to avoid thinking about death, their sense of connectedness (to themselves, to others, and to the wider world/universe), and the intensity of any mystical-type experiences during their psychedelic session.
The results were consistent. Participants reported a significantly lower fear of death and significantly less death avoidance after their psychedelic experience compared to before. At the same time, they reported significantly greater connectedness across all three domains.
Crucially, the study found that these changes moved together. People who gained more in their sense of connection to themselves, to others, and to the world were more likely to have also experienced the greatest reductions in their fear of death. Stronger mystical experiences—characterized by feelings of cosmic unity and transcendence—were similarly associated with greater connectedness and a lower fear of death.
However, the findings became more complex when looking at death avoidance—defined as the tendency to actively keep thoughts of death out of conscious awareness. Increases in connectedness to oneself and to others were linked to lower death avoidance. But an increased connectedness to the world, as well as intense mystical experiences, did not predict lower levels of death avoidance.
The authors suggest this split points to two very different ways people process death after a trip. Feeling more connected to oneself and loved ones seems to promote genuine existential acceptance, where a person stops avoiding the topic of death and stops fearing it.
Conversely, intense mystical experiences may promote a “defensive shift.” A person who feels cosmically connected to the universe may stop fearing death, but they still actively avoid thinking about it—likely because the drug changed their metaphysical beliefs, allowing them to bypass human mortality by believing they will merge with the cosmos when they die.
“An important unresolved question is whether reductions in death anxiety following a psychedelic experience arise through defensive denialistic bypassing or through acceptance and integration of mortality,” Barr and colleagues concluded.
There are significant limitations to keep in mind. Chiefly, the study’s retrospective design—asking participants to recall and compare their mental states from months or years prior—is inherently vulnerable to recall bias, selective memory, and the tendency for a person to unconsciously exaggerate how bad they felt before a life-changing event to make the transformation seem more profound.
The study, “Exploring associations between connectedness and death anxiety following a psychedelic experience,” was authored by Noah N. Barr, Briony Larance, Matthew J. Schweickle, and Sam G. Moreton.
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #PsychedelicStudies #DeathAnxiety #MysticalExperience #Psychedelics # psilocybin #LSD #Ayahuasca #DMT #Mindfulness #Connectedness
-
DATE: May 11, 2026 at 10:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: New study explores the link between mystical psychedelic trips and a reduced fear of dying
A new study published in the Journal of Psychedelic Studies has found that people who have had a meaningful psychedelic experience report a significantly reduced fear of death, alongside heightened feelings of connection to themselves, others, and the world around them. Furthermore, the degree of connection closely tracks the degree of relief from death-related fear.
Researchers have long argued that anxiety about dying sits at the root of a surprisingly wide range of psychological struggles, from depression to broader existential distress. Studies have observed that psychedelic experiences—first noted in terminally ill patients in the mid-20th century and later confirmed in modern controlled research—can drastically reduce this fear, though the mechanisms behind why this happens remain unclear.
One leading explanation is increased connectedness: a heightened sense of relationship to oneself, others, and the wider world. Because psychedelics reliably enhance these feelings, researchers sought to investigate whether greater connectedness might be one of the specific pathways through which psychedelics reduce the fear of death.
Led by Noah N. Barr at the University of Wollongong in Australia, the team recruited 106 adults (59 male, 44 female, 2 non-binary; average age 31 years) who had undergone a personally meaningful psychedelic experience using a classical substance. Psilocybin (the active compound in “magic mushrooms”) was the most common, though LSD, ayahuasca, DMT, and mescaline were also represented.
Using an anonymous online survey, participants reflected retrospectively on the three months before and the three months after their experience. They completed validated questionnaires measuring their fear of death, their tendency to avoid thinking about death, their sense of connectedness (to themselves, to others, and to the wider world/universe), and the intensity of any mystical-type experiences during their psychedelic session.
The results were consistent. Participants reported a significantly lower fear of death and significantly less death avoidance after their psychedelic experience compared to before. At the same time, they reported significantly greater connectedness across all three domains.
Crucially, the study found that these changes moved together. People who gained more in their sense of connection to themselves, to others, and to the world were more likely to have also experienced the greatest reductions in their fear of death. Stronger mystical experiences—characterized by feelings of cosmic unity and transcendence—were similarly associated with greater connectedness and a lower fear of death.
However, the findings became more complex when looking at death avoidance—defined as the tendency to actively keep thoughts of death out of conscious awareness. Increases in connectedness to oneself and to others were linked to lower death avoidance. But an increased connectedness to the world, as well as intense mystical experiences, did not predict lower levels of death avoidance.
The authors suggest this split points to two very different ways people process death after a trip. Feeling more connected to oneself and loved ones seems to promote genuine existential acceptance, where a person stops avoiding the topic of death and stops fearing it.
Conversely, intense mystical experiences may promote a “defensive shift.” A person who feels cosmically connected to the universe may stop fearing death, but they still actively avoid thinking about it—likely because the drug changed their metaphysical beliefs, allowing them to bypass human mortality by believing they will merge with the cosmos when they die.
“An important unresolved question is whether reductions in death anxiety following a psychedelic experience arise through defensive denialistic bypassing or through acceptance and integration of mortality,” Barr and colleagues concluded.
There are significant limitations to keep in mind. Chiefly, the study’s retrospective design—asking participants to recall and compare their mental states from months or years prior—is inherently vulnerable to recall bias, selective memory, and the tendency for a person to unconsciously exaggerate how bad they felt before a life-changing event to make the transformation seem more profound.
The study, “Exploring associations between connectedness and death anxiety following a psychedelic experience,” was authored by Noah N. Barr, Briony Larance, Matthew J. Schweickle, and Sam G. Moreton.
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #PsychedelicStudies #DeathAnxiety #MysticalExperience #Psychedelics # psilocybin #LSD #Ayahuasca #DMT #Mindfulness #Connectedness
-
DATE: May 11, 2026 at 10:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: New study explores the link between mystical psychedelic trips and a reduced fear of dying
A new study published in the Journal of Psychedelic Studies has found that people who have had a meaningful psychedelic experience report a significantly reduced fear of death, alongside heightened feelings of connection to themselves, others, and the world around them. Furthermore, the degree of connection closely tracks the degree of relief from death-related fear.
Researchers have long argued that anxiety about dying sits at the root of a surprisingly wide range of psychological struggles, from depression to broader existential distress. Studies have observed that psychedelic experiences—first noted in terminally ill patients in the mid-20th century and later confirmed in modern controlled research—can drastically reduce this fear, though the mechanisms behind why this happens remain unclear.
One leading explanation is increased connectedness: a heightened sense of relationship to oneself, others, and the wider world. Because psychedelics reliably enhance these feelings, researchers sought to investigate whether greater connectedness might be one of the specific pathways through which psychedelics reduce the fear of death.
Led by Noah N. Barr at the University of Wollongong in Australia, the team recruited 106 adults (59 male, 44 female, 2 non-binary; average age 31 years) who had undergone a personally meaningful psychedelic experience using a classical substance. Psilocybin (the active compound in “magic mushrooms”) was the most common, though LSD, ayahuasca, DMT, and mescaline were also represented.
Using an anonymous online survey, participants reflected retrospectively on the three months before and the three months after their experience. They completed validated questionnaires measuring their fear of death, their tendency to avoid thinking about death, their sense of connectedness (to themselves, to others, and to the wider world/universe), and the intensity of any mystical-type experiences during their psychedelic session.
The results were consistent. Participants reported a significantly lower fear of death and significantly less death avoidance after their psychedelic experience compared to before. At the same time, they reported significantly greater connectedness across all three domains.
Crucially, the study found that these changes moved together. People who gained more in their sense of connection to themselves, to others, and to the world were more likely to have also experienced the greatest reductions in their fear of death. Stronger mystical experiences—characterized by feelings of cosmic unity and transcendence—were similarly associated with greater connectedness and a lower fear of death.
However, the findings became more complex when looking at death avoidance—defined as the tendency to actively keep thoughts of death out of conscious awareness. Increases in connectedness to oneself and to others were linked to lower death avoidance. But an increased connectedness to the world, as well as intense mystical experiences, did not predict lower levels of death avoidance.
The authors suggest this split points to two very different ways people process death after a trip. Feeling more connected to oneself and loved ones seems to promote genuine existential acceptance, where a person stops avoiding the topic of death and stops fearing it.
Conversely, intense mystical experiences may promote a “defensive shift.” A person who feels cosmically connected to the universe may stop fearing death, but they still actively avoid thinking about it—likely because the drug changed their metaphysical beliefs, allowing them to bypass human mortality by believing they will merge with the cosmos when they die.
“An important unresolved question is whether reductions in death anxiety following a psychedelic experience arise through defensive denialistic bypassing or through acceptance and integration of mortality,” Barr and colleagues concluded.
There are significant limitations to keep in mind. Chiefly, the study’s retrospective design—asking participants to recall and compare their mental states from months or years prior—is inherently vulnerable to recall bias, selective memory, and the tendency for a person to unconsciously exaggerate how bad they felt before a life-changing event to make the transformation seem more profound.
The study, “Exploring associations between connectedness and death anxiety following a psychedelic experience,” was authored by Noah N. Barr, Briony Larance, Matthew J. Schweickle, and Sam G. Moreton.
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #PsychedelicStudies #DeathAnxiety #MysticalExperience #Psychedelics # psilocybin #LSD #Ayahuasca #DMT #Mindfulness #Connectedness
-
#Israël : la drug-nation blanchit la #guerre
Depuis le 7 octobre 2023, des #drogues sont administrées à des milliers de militaires au retour de #Gaza. Du #cannabis au #LSD en passant par l’ #ecstasy, tout est bon pour traiter les troubles post-traumatiques https://orientxxi.info/Israel-la-drug-nation-blanchit-la-guerre
#actu #info #information #actualite #palestine #freepalestine #genocide #stopgenocide #armee #militaire
-
#Israël : la drug-nation blanchit la #guerre
Depuis le 7 octobre 2023, des #drogues sont administrées à des milliers de militaires au retour de #Gaza. Du #cannabis au #LSD en passant par l’ #ecstasy, tout est bon pour traiter les troubles post-traumatiques https://orientxxi.info/Israel-la-drug-nation-blanchit-la-guerre
#actu #info #information #actualite #palestine #freepalestine #genocide #stopgenocide #armee #militaire
-
#Israël : la drug-nation blanchit la #guerre
Depuis le 7 octobre 2023, des #drogues sont administrées à des milliers de militaires au retour de #Gaza. Du #cannabis au #LSD en passant par l’ #ecstasy, tout est bon pour traiter les troubles post-traumatiques https://orientxxi.info/Israel-la-drug-nation-blanchit-la-guerre
#actu #info #information #actualite #palestine #freepalestine #genocide #stopgenocide #armee #militaire
-
#Israël : la drug-nation blanchit la #guerre
Depuis le 7 octobre 2023, des #drogues sont administrées à des milliers de militaires au retour de #Gaza. Du #cannabis au #LSD en passant par l’ #ecstasy, tout est bon pour traiter les troubles post-traumatiques https://orientxxi.info/Israel-la-drug-nation-blanchit-la-guerre
#actu #info #information #actualite #palestine #freepalestine #genocide #stopgenocide #armee #militaire
-
#Israël : la drug-nation blanchit la #guerre
Depuis le 7 octobre 2023, des #drogues sont administrées à des milliers de militaires au retour de #Gaza. Du #cannabis au #LSD en passant par l’ #ecstasy, tout est bon pour traiter les troubles post-traumatiques https://orientxxi.info/Israel-la-drug-nation-blanchit-la-guerre
#actu #info #information #actualite #palestine #freepalestine #genocide #stopgenocide #armee #militaire
-
Free download codes:
Deep N Beeper - Acid N Bass
"Expect the unexpected in BASS music"
#electronic #electronica #idm #drumandbass #acid #rave #dubstep #drum bass #dnb #140 #futurebass #140bpm #lsd #multiverse #london #music
-
Free download codes:
Deep N Beeper - Acid N Bass
"Expect the unexpected in BASS music"
#electronic #electronica #idm #drumandbass #acid #rave #dubstep #drum bass #dnb #140 #futurebass #140bpm #lsd #multiverse #london #music
-
Free download codes:
Deep N Beeper - Acid N Bass
"Expect the unexpected in BASS music"
#electronic #electronica #idm #drumandbass #acid #rave #dubstep #drum bass #dnb #140 #futurebass #140bpm #lsd #multiverse #london #music
-
Free download codes:
Deep N Beeper - Acid N Bass
"Expect the unexpected in BASS music"
#electronic #electronica #idm #drumandbass #acid #rave #dubstep #drum bass #dnb #140 #futurebass #140bpm #lsd #multiverse #london #music
-
DATE: May 9, 2026 at 08:00PM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Real world outcomes support the benefits of psychedelic therapy for severe depression
A recent study has found that specialized psychotherapy paired with doses of either LSD or psilocybin is associated with strong reductions in severe depression and anxiety. These mental health improvements emerged relatively quickly and took place within a standard hospital care program. The findings were published in the journal Psychiatry Research.
In recent years, researchers have renewed their investigation into the medical potential of classic hallucinogens. Conditions like severe depression and generalized anxiety do not always respond to standard psychiatric medications. For many individuals, initial treatments such as selective serotonin reuptake inhibitors fail to provide lasting relief from persistent sad moods or chronic worry.
Individuals who do not respond to multiple standard treatments are often diagnosed with treatment-resistant conditions. This status leaves them with limited options in conventional medical practice. Psychedelic-assisted therapy has emerged as a promising alternative for these populations in strictly monitored experimental trials.
These therapies combine traditional talk therapy with the ingestion of a mind-altering substance under professional supervision. The goal is to induce a temporary change in consciousness that allows patients to process difficult emotions. A trained therapist helps the patient integrate these conceptual insights into their daily life after the drug effects wear off.
Most of the current evidence for these treatments comes from randomized controlled trials. While these trials offer rigorous baseline data, they often exclude patients with varied medical histories to isolate a specific chemical variable. This strict filtering means the results do not always translate perfectly to general hospital populations.
To understand how these treatments perform outside of rigid experiments, researchers look to compassionate use programs. These legal frameworks allow doctors to administer unapproved, experimental medications to patients who have exhausted all other available therapies. Switzerland operates one such framework, giving doctors restricted authorization to use specialized substances for severe mental health cases.
Tatiana Aboulafia-Brakha, a researcher at the Geneva University Hospitals, led an effort to analyze data from one of these Swiss clinical programs. Aboulafia-Brakha and her team wanted to evaluate the outcomes of patients receiving these therapies in a routine hospital setting. They sought to document changes in mental health symptoms and to record how well patients tolerated the experience.
The team collected retrospective data from a cohort of adults diagnosed with treatment-resistant depressive or anxiety disorders. This cohort underwent their first standardized treatment cycle between May 2024 and October 2025. Each individual received either 100 micrograms of LSD or 25 milligrams of psilocybin during their session.
Psilocybin is the primary psychoactive compound found in certain species of hallucinogenic mushrooms. LSD is a synthetic chemical known for producing potent shifts in perception and thought patterns. Patients were allowed to choose their preferred substance based on personal comfort, anticipated session length, and cost.
The program required extensive preparation before the actual administration of the drug. Patients attended screening sessions to review their medical histories and ensure no underlying heart or neurological conditions existed. They also engaged in preparatory meetings to set therapeutic intentions and learn coping strategies like breathing exercises for managing acute moments of fear.
On the day of the treatment, patients arrived at an outpatient clinic and settled into a quiet room under the constant supervision of psychiatric nurses. The nurses monitored vital signs and intervened only if the patient requested support or required help navigating a challenging psychological reaction. The patients then remained in the clinic until the acute subjective effects had completely resolved.
Patients returned the following day for an integration session with a psychotherapist. During this conversation, patients discussed the imagery, body sensations, and emotional revelations they experienced while receiving the drug. The therapist then helped them translate those abstract insights into actionable behavioral routines.
To quantify the results, the researchers administered standard psychological questionnaires at three distinct points in time. Patients filled out surveys during their initial screening, one month before the treatment, and one to three months after the session. These tools measured the severity of general sadness, pessimism, and habitual stress responses.
The team observed a pronounced decrease in both depression and anxiety scores over the treatment timeline. More than a third of the sample reported that their depressive symptoms had been reduced by at least half. A smaller portion recorded modest but noticeable symptom relief. These benefits appeared robust across the broader cohort, supporting previous findings from highly controlled laboratory environments.
The choice of substance did not seem to alter the long-term therapeutic outcome. Patients who took LSD and those who took psilocybin experienced largely identical improvements in their daily mental health.
Aboulafia-Brakha and her team also investigated how patients managed their emotions before and after the treatments. A subset of the patients completed an emotion regulation survey measuring strategies like rumination and catastrophizing. Rumination involves repetitively dwelling on negative feelings, while catastrophizing is a tendency to expect the worst possible outcome in any situation.
Following the therapy, patients reported large reductions in their tendencies to ruminate, catastrophize, and blame themselves for negative life events. They also demonstrated an increased capacity for positive reappraisal, which means they could more easily find a constructive perspective in difficult situations. These conceptual shifts align with psychological theories that consider rigid thinking to be a primary maintenance factor for severe depression.
While the long-term clinical benefits were similar across both substances, the acute physical experiences differed notably. The data indicated that LSD produced a longer, sustained plateau of intense subjective effects. Psilocybin caused a similar peak of intensity, but the overall duration of the psychoactive experience was noticeably shorter.
Despite these differing timelines, the overall intensity of the mystical experiences reported by the patients was roughly equivalent. Questionnaires measuring profound feelings of unity, distinct alterations in time perception, and deep spiritual insight yielded similar scores. These outcomes support the concept that the subjective journey might matter more than the specific pharmacological timeline.
Safety evaluations showed that both substances were well tolerated within the hospital environment. Many patients reported no adverse reactions at all, while the majority of recorded side effects were mild and temporary. The most common physical complaints included transient blurred vision, dizziness, and mild nausea during the active phase of the medication.
The team recorded no serious medical complications or severe psychiatric emergencies during the study period. No patient discontinued the treatment due to an adverse reaction. These details provide reassuring baseline evidence for medical professionals worried about introducing potent hallucinogens into general outpatient clinics.
This study has a few limitations due to its retrospective design and observational nature. The researchers did not include a placebo group, which means they cannot entirely rule out the influence of patient expectations. Patients who pursue rigorous medical treatments often expect to feel better, and this hope can artificially inflate self-reported symptom relief.
The cohort was highly motivated, considering the long waiting times and financial costs associated with the compassionate use program. This unique determination among the participants might mean the results would be different in a less motivated patient population. The reliance on self-reported questionnaires also leaves room for memory biases to influence the data.
Future studies will need to implement randomized designs involving active placebos to better isolate the specific physiological effects of the therapy. Combining patient self-reports with objective evaluations from independent clinicians could ensure a more reliable assessment of long-term improvement. Until then, these findings offer an encouraging glimpse into the practical realities of psychedelic therapies in standard psychiatric settings.
The study, “Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland,” was authored by T. Aboulafia-Brakha, A. Buchard, C. Mabilais, S. Alaux, C. Amberger, L. Furtado, F. Seragnoli, J-F Briefer, G. Thorens, M. Sabé, L. Szczesniak, R. Iuga, D. Zullino, and L. Penzenstadler.
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #PsychedelicAssistedPsychotherapy #DepressionTreatment #LSD #Psilocybin #MentalHealthTherapy #CompassionateUse #RealWorldEvidence #AnxietyRelief #PsychiatricCare #HolisticHealing
-
https://www.europesays.com/it/468661/ Robert Mapplethorpe. Sensuale classicità in mostra a Palazzo Reale #aids #AndyWarhol #Arte #ArteEDesign #ArteEdesign #Arts #ArtsAndDesign #collage #cultura #DenisCurti #Design #Entertainment #FondazioneRobertMapplethorpe #fotografia #GreenwichVillage #GuerraVietnam #HotelChelsea #Intrattenimento #IT #Italia #Italy #LisaLyon #lombardia #LSD #MarsiioArte #milano #MostreFotografiche #MovimentoGay #PalazzoRealeMilano #PattySmith #RobertMapplethorpe
-
RE: https://piaille.fr/@Oam_Gui/116464547134204997
🔴 Live lancé !
ÉCOLOGIE ET RÉSISTANCE 🌱✊ | Fin du mois, fin du monde, même combat 💸🌍 (LSD, La Série Documentaire)
➡️ https://www.twitch.tv/oamgui
-
#réact #podcast #écologie #justicesociale #LSD
@pogscience.bsky.social -
RE: https://piaille.fr/@Oam_Gui/116345638926412342
🗓️ Live aujourd'hui - 12h !
On continue le réact au podcast ÉCOLOGIE ET RÉSISTANCE 🌱✊
Sujet : « Fin du mois, fin du monde, même combat 💸🌍 »
👉 Comment faire de l'écologie une cause populaire ?
RDV sur Twitch ➡️ https://www.twitch.tv/oamgui
-
Free download codes:
Deep N Beeper - 5D's 140 "DUB" Pack [2025 ReMasters]
"DEEP AF BASS AND BEATS (140/Dubstep)"
#electronic #electronica #idm #acid #rave #dnb #140 #futurebass #140bpm #deepdubstep #lsd #multiverse #london #music
-
Die Polizei hat in Dülmen ein Drogenlabor ausgehoben. Die Drogen haben einen Wert von 200.000 Euro.#WDR #Polizei #Drogen #Drogenfund #Drogenlabor #Dülmen #LSD #Kokain #Heroin #NRW
Betäubungsmittel im Wert von 200.000 Euro: Polizei hebt in Dülmen Drogenlabor aus -
Free download codes:
Deep N Beeper - 5D's 140 "DUB" Pack [2025 ReMasters]
"DEEP AF BASS AND BEATS (140/Dubstep)"
#electronic #electronica #idm #acid #rave #dnb #140 #futurebass #140bpm #deepdubstep #lsd #multiverse #london #music
-
Trump signs order to accelerate access to psychedelic drug treatments
-
Trump signs order to accelerate access to psychedelic drug treatments
-
Trump signs order to accelerate access to psychedelic drug treatments
-
Trump signs order to accelerate access to psychedelic drug treatments
-
Trump signs order to accelerate access to psychedelic drug treatments
-
@simonwilliamson @MarkAsser @TheBreadmonkey
Maybe the surprise is the effect of the drug?https://m.youtube.com/watch?v=TKBa09XGLtA
#drugs #LSD #drugTrials #science #war #royalMarines #soldiering
-
https://en.wikipedia.org/wiki/LSD#History
The first intentional ingestion of #LSD occurred on April 19, 1943, when Hofmann ingested 250 μg of LSD.
-
More frog-folk blotters!! 🐸🔮✨️ lookin' juicyy 🫠
#frog #blotter #acid #LSD #psychdelics #psychedelic #bicycleday #hofmann #trippy #toad #blotters #print #merch #fantasy #fantasyart #artist #MastoArt #artistsonmastodon #ArcaneCluster #Arcane #Cluster
-
More frog-folk blotters!! 🐸🔮✨️ lookin' juicyy 🫠
#frog #blotter #acid #LSD #psychdelics #psychedelic #bicycleday #hofmann #trippy #toad #blotters #print #merch #fantasy #fantasyart #artist #MastoArt #artistsonmastodon #ArcaneCluster #Arcane #Cluster
-
More frog-folk blotters!! 🐸🔮✨️ lookin' juicyy 🫠
#frog #blotter #acid #LSD #psychdelics #psychedelic #bicycleday #hofmann #trippy #toad #blotters #print #merch #fantasy #fantasyart #artist #MastoArt #artistsonmastodon #ArcaneCluster #Arcane #Cluster
-
More frog-folk blotters!! 🐸🔮✨️ lookin' juicyy 🫠
#frog #blotter #acid #LSD #psychdelics #psychedelic #bicycleday #hofmann #trippy #toad #blotters #print #merch #fantasy #fantasyart #artist #MastoArt #artistsonmastodon #ArcaneCluster #Arcane #Cluster
-
Nochmal hieran https://chaos.social/@frumble/114622415670884722 anschließend:
»So almost 10 years ago I had the same experience where I was breaking through the veil probably 5 to 10 times and after I did #DMT the first time every time I did anything else it revealed itself to allow me to go further. Whether that was shrooms, #LSD, or DMT. The door was there. Upon the final time that I broke through the veil the beings looked at me and said why are you here again we told you to come back naturally. …
-
Nochmal hieran https://chaos.social/@frumble/114622415670884722 anschließend:
»So almost 10 years ago I had the same experience where I was breaking through the veil probably 5 to 10 times and after I did #DMT the first time every time I did anything else it revealed itself to allow me to go further. Whether that was shrooms, #LSD, or DMT. The door was there. Upon the final time that I broke through the veil the beings looked at me and said why are you here again we told you to come back naturally. …
-
Nochmal hieran https://chaos.social/@frumble/114622415670884722 anschließend:
»So almost 10 years ago I had the same experience where I was breaking through the veil probably 5 to 10 times and after I did #DMT the first time every time I did anything else it revealed itself to allow me to go further. Whether that was shrooms, #LSD, or DMT. The door was there. Upon the final time that I broke through the veil the beings looked at me and said why are you here again we told you to come back naturally. …
-
Nochmal hieran https://chaos.social/@frumble/114622415670884722 anschließend:
»So almost 10 years ago I had the same experience where I was breaking through the veil probably 5 to 10 times and after I did #DMT the first time every time I did anything else it revealed itself to allow me to go further. Whether that was shrooms, #LSD, or DMT. The door was there. Upon the final time that I broke through the veil the beings looked at me and said why are you here again we told you to come back naturally. …
-
Nochmal hieran https://chaos.social/@frumble/114622415670884722 anschließend:
»So almost 10 years ago I had the same experience where I was breaking through the veil probably 5 to 10 times and after I did #DMT the first time every time I did anything else it revealed itself to allow me to go further. Whether that was shrooms, #LSD, or DMT. The door was there. Upon the final time that I broke through the veil the beings looked at me and said why are you here again we told you to come back naturally. …
-
Single Dose of #DMT Rapidly Reduces Symptoms of Major #Depression
Unlike #psilocybin and lysergic acid diethylamide (#LSD), whose effects last for hours, intravenous DMT has half-life of around five minutes. Its #psychedelic effects are correspondingly brief, potentially making it more practical to administer in clinical settings.
Two weeks after the first dose, participants who received DMT scored about seven points lower, on average, than those who received a placebo.
https://www.sciencealert.com/single-dose-of-dmt-rapidly-reduces-symptoms-of-major-depression
